The estimated Net Worth of Samit Hirawat is at least $3.9 Milión dollars as of 10 March 2024. Mr. Hirawat owns over 38,388 units of Bristol-Myers Squibb Co stock worth over $3,899,639 and over the last 5 years he sold BMY stock worth over $0. In addition, he makes $0 as Executive Vice President, Chief Medical Officer a Global Drug Development Member of the Leadership Team at Bristol-Myers Squibb Co.
Samit has made over 8 trades of the Bristol-Myers Squibb Co stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 38,388 units of BMY stock worth $1,865,273 on 10 March 2024.
The largest trade he's ever made was exercising 38,978 units of Bristol-Myers Squibb Co stock on 10 March 2023 worth over $1,893,941. On average, Samit trades about 12,805 units every 135 days since 2019. As of 10 March 2024 he still owns at least 80,256 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Hirawat stock trades at the bottom of the page.
Samit Hirawat M.D. serves as Executive Vice President, Chief Medical Officer, Global Drug Development Member of the Leadership Team of the Company. 2012 to 2016 – Senior Vice President & Global Program Head, Novartis 2017 to 2019 – Executive Vice President, Head of Oncology Development, Novartis 2019 to present – Executive Vice President, Chief Medical Officer, Global Drug Development.
Samit Hirawat is 51, he's been the Executive Vice President, Chief Medical Officer a Global Drug Development Member of the Leadership Team of Bristol-Myers Squibb Co since 2019. There are 30 older and 4 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Samit's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius a Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: